zł672.00
0.89% yesterday
Warsaw, Oct 06, 04:49 pm CET
ISIN
PLTRFRM00018
Symbol
NEU

Neuca Stock price

zł672.00
-30.00 4.27% 1M
+7.91 1.19% 6M
-180.58 21.18% YTD
-127.84 15.98% 1Y
+72.44 12.08% 3Y
+205.19 43.96% 5Y
+381.55 131.36% 10Y
+645.14 2,401.60% 20Y
Warsaw, Closing price Mon, Oct 06 2025
-6.00 0.89%
ISIN
PLTRFRM00018
Symbol
NEU

Key metrics

Basic
Market capitalization
zł3.1b
Enterprise Value
zł3.5b
Net debt
zł448.2m
Cash
zł154.0m
Shares outstanding
4.5m
Valuation (TTM | estimate)
P/E
23.0 | 18.9
P/S
0.2 | 0.2
EV/Sales
0.3 | 0.3
EV/FCF
29.8
P/B
2.9
Dividends
DPS
zł16.00
Yield 1Y | 5Y
2.4% | 1.9%
Growth 1Y | 5Y
10.3% | 13.1%
Payout 1Y | 3Y
47.0% | 45.1%
Increased
19 Years
Financials (TTM | estimate)
Revenue
zł13.0b | zł13.4b
EBITDA
zł372.6m | zł406.5m
EBIT
zł249.0m | zł279.2m
Net Income
zł135.4m | zł161.1m
Free Cash Flow
zł117.6m
Growth (TTM | estimate)
Revenue
7.6% | 6.1%
EBITDA
-7.7% | 2.8%
EBIT
-12.7% | 1.4%
Net Income
-17.7% | 4.4%
Free Cash Flow
-46.6%
Margin (TTM | estimate)
Gross
11.4%
EBITDA
2.9% | 3.0%
EBIT
1.9%
Net
1.0% | 1.2%
Free Cash Flow
0.9%
Financial Health
Equity Ratio
20.7%
Return on Equity
13.5%
ROCE
15.8%
ROIC
9.6%
Debt/Equity
0.6
More
EPS
zł29.5
FCF per Share
zł26.3
Short interest
-
Employees
5k
Rev per Employee
zł2.7m
Show more

Is Neuca a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,001 stocks worldwide.

Neuca Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Neuca forecast:

5x Buy
63%
2x Hold
25%
1x Sell
13%

Analyst Opinions

8 Analysts have issued a Neuca forecast:

Buy
63%
Hold
25%
Sell
13%

Financial data from Neuca

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
13,040 13,040
8% 8%
100%
- Direct Costs 11,552 11,552
8% 8%
89%
1,488 1,488
7% 7%
11%
- Selling and Administrative Expenses 1,229 1,229
10% 10%
9%
- Research and Development Expense - -
-
-
373 373
8% 8%
3%
- Depreciation and Amortization 124 124
4% 4%
1%
EBIT (Operating Income) EBIT 249 249
13% 13%
2%
Net Profit 135 135
18% 18%
1%

In millions PLN.

Don't miss a Thing! We will send you all news about Neuca directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

NEUCA SA engages in the wholesale of pharmaceutical products. It operates through the following segments: Pharmaceutical Wholesale; Own Brands; and Outpatient Care Clinics, Clinical Trials, and Telemedicine. The Pharmaceutical Wholesale segment provides medical products for pharmacies. The Own Brands segment comprises market launching of pharmaceutical products under own brand. The Outpatient Care Clinics, Clinical Trials, and Telemedicine segment activities include general medical practice, clinical trials, and telemedicine. The company was founded by Kazimierz Michal Herba in 1990 and is headquartered in Torun, Poland.

Head office Poland
CEO Piotr Sucharski
Employees 4,633
Founded 1990
Website www.neuca.pl

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today